David Boyer
0000-0001-9219-1614
Retina Vitreous Associates
1 paper found
Refreshing results…
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration
Missing publications? Search for publications with a matching author name.